• Explore /
  • Poster
  • / Cost implications of reactive versus prospective testing for dihydropyrimidine dehydrogenase (DPD) deficiency in patients with colorectal cancer.

Cost implications of reactive versus prospective testing for dihydropyrimidine dehydrogenase (DPD) deficiency in patients with colorectal cancer.

Abstract Poster

Authors

null

Gul Ahmed

Bon Secours Hospital, Cork, Ireland

Gul Ahmed , Jo O' Keeffe , Denise O Mullane , Alison Bransfield , Andrew Kenny , Aiman Mohd Nor , Nurul Asykin Hashim , Roisin O Sullivan , Kate Murphy , Raimundas Galiauskas , Brian Richard Bird , Conleth G. Murphy

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3627)

DOI

10.1200/jco.2013.31.15_suppl.3627

Abstract #

3627

Poster Bd #

12E

Abstract Disclosures

Similar Posters

First Author: Jai Narendra Patel

First Author: Gabriel Brooks

First Author: Gabriel A. Brooks

First Author: Garrett Rompelman